# Woman with Ultra-Rare Disease Secures Clinical Trial Treatment trial initiated for a disease affecting only 30 people worldwide. - **Source:** [NYT > Science](https://brifing.si/source/794f9fbd-c10f-44d6-932d-9039af67922c) - **Published:** 2026-08-17 - **Original article:** - **On Brifing:** https://brifing.si/s/851cba8a-3840-44dc-97df-f4630a554474 ## Living with a Rare Disease Neena Nizar battles an extremely rare genetic disorder affecting just 30 people globally. The condition causes bone deformities and severe pain. It's so uncommon that diagnosis took years. Nizar visited numerous doctors before receiving the correct identification of her condition. ## Quest for Treatment After diagnosis, Nizar learned there was no cure for her disease. Available medications only addressed symptoms. This realization drove her to research potential scientific solutions. She experienced firsthand the challenges of clinical trials for rare diseases. ## Patient Advocacy Nizar began reviewing scientific literature about her condition. She reached out to researchers and shared her story. Collaborating with rare disease specialists, she understood the power of patient advocacy. This inspired her to become a beacon of hope for others. ## Clinical Trial Process Nizar's efforts led to development of an experimental treatment protocol. Researchers created a potential therapeutic approach. To test its safety and efficacy, a clinical trial was initiated. Nizar became the first participant in this groundbreaking study. ## Scientific Collaboration The trial brought together multidisciplinary experts. Geneticists, orthopedists, and pharmacologists worked collaboratively. They addressed unique challenges of rare disease research. This cooperation established a model process for similar conditions. ## Ethical Approvals The trial obtained necessary ethics committee approvals. Patient safety remained paramount throughout protocol development. Every trial phase was meticulously planned and documented. The process prompted reevaluation of rare disease research standards. ## Treatment Hope If successful, this treatment could benefit patients with similar rare disorders. The trial represents significant progress in personalized medicine. Nizar's story highlights the crucial role of patient involvement in medical research. ## Rare Disease Awareness This case demonstrates the power of patient advocacy in rare diseases. Approximately 300 million people worldwide live with rare conditions. Nizar's success inspires others and underscores the need for patient-centered research approaches. ## Sources covering this story - https://www.nytimes.com/2026/08/17/science/clinical-trial-jansens-disease-nizar-nih.html — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._